NCT02536287

Brief Summary

The purpose of this study is to compare short-term and long-term efficacy of total parathyroidectomy with autotransplantation and total parathyroidectomy without autotransplantation for Secondary hyperparathyroidism.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Sep 2015

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 31, 2015

Completed
1 day until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

August 31, 2015

Status Verified

August 1, 2015

Enrollment Period

1.3 years

First QC Date

August 22, 2015

Last Update Submit

August 26, 2015

Conditions

Keywords

secondary hyperparathyroidismtotal parathyroidectomyautotransplantationmorbidityrecurrencepostoperative hypocalcemia

Outcome Measures

Primary Outcomes (1)

  • Change of intact parathyroid hormone(iPTH)

    Intact parathyroid hormone was collected before operation,1 day,1 week,1 month,3 months,6 months,12 months,18 months and 24months after the operation

    1 day,1 week,1,3,6,12,18 and 24months

Secondary Outcomes (10)

  • Change of serum calcium

    1 day,1 week,1,3,6,12,18 and 24months

  • Change of serum phosphorus

    1 day,1 week,1,3,6,12,18 and 24months

  • Change of calcium-phosphorus product

    1 day,1 week,1,3,6,12,18 and 24months

  • Change of hemoglobin

    1 day,1 week,1,3,6,12,18 and 24months

  • Operation time

    an expected average of 1.5 hours

  • +5 more secondary outcomes

Study Arms (2)

total PTX without autotransplantation

EXPERIMENTAL

all parathyroid glands were found and removed

Procedure: total PTX without autotransplantation

total PTX with autotransplantation

ACTIVE COMPARATOR

all parathyroid glands were found and removed,and then a portion of it is sliced into 1\*1\*1 mm pieces for autotransplantation

Procedure: total PTX with autotransplantation

Interventions

All parathyroid glands were found and removed and sent for histological confirmation,but without autotransplantation.

total PTX without autotransplantation

All parathyroid glands were found and removed and sent for histological confirmation,and then a portion of the smallest, preferably nonnodular parathyroid gland was chosen for autotransplantation,sliced into pieces measuring 1\*1 \*1 mm,and placed into the subcutaneous of the forearm.

total PTX with autotransplantation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both male and female, aged 18 or older;
  • Intact parathyroid hormone(iPTH) is more than 9 times the upper limit of the normal range (about 600pg/ml), with hypercalcemia or hyperphosphatemia;
  • Refractory to medical therapy;
  • Provided written informed consent.

You may not qualify if:

  • Primary or tertiary hyperparathyroidism;
  • Familial hyperparathyroidism (MENⅠ, MENⅡ, hereditary HPT);
  • Neck surgical exploration history;
  • Parathyroid malignant tumor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Second Affiliated Hospital of Anhui Medical University

Hefei, Anhui, 230022, China

Location

Related Publications (5)

  • Puccini M, Carpi A, Cupisti A, Caprioli R, Iacconi P, Barsotti M, Buccianti P, Mechanick J, Nicolini A, Miccoli P. Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother. 2010 May;64(5):359-62. doi: 10.1016/j.biopha.2009.06.006. Epub 2009 Oct 23.

  • Jia X, Wang R, Zhang C, Cui M, Xu D. Long-Term Outcomes of Total Parathyroidectomy With or Without Autoimplantation for Hyperparathyroidism in Chronic Kidney Disease: A Meta-Analysis. Ther Apher Dial. 2015 Oct;19(5):477-85. doi: 10.1111/1744-9987.12310. Epub 2015 May 6.

  • Tominaga Y, Matsuoka S, Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial. 2005 Feb;9(1):44-7. doi: 10.1111/j.1774-9987.2005.00213.x.

  • Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I, Hachisuka T, Takagi H. More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S168-71. doi: 10.1053/ajkd.2001.27432.

  • Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg. 2012 Feb;36(2):318-26. doi: 10.1007/s00268-011-1392-0.

MeSH Terms

Conditions

Hyperparathyroidism, SecondaryRecurrence

Interventions

Transplantation, Autologous

Condition Hierarchy (Ancestors)

HyperparathyroidismParathyroid DiseasesEndocrine System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, Operative

Study Officials

  • xiaoping geng, professor

    the vice President of the second affiliated hospitalof Anhui medical university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

xiaoping geng, professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice-president

Study Record Dates

First Submitted

August 22, 2015

First Posted

August 31, 2015

Study Start

September 1, 2015

Primary Completion

December 1, 2016

Study Completion

December 1, 2018

Last Updated

August 31, 2015

Record last verified: 2015-08

Locations